前列腺癌
肿瘤科
比例危险模型
医学
内科学
危险系数
癌症
支票2
癌症研究
生物
基因
突变
种系突变
遗传学
置信区间
作者
Heidi Fettke,Chao Dai,Edmond M. Kwan,Tiantian Zheng,Pan Du,Nicole Ng,Patricia Bukczynska,Maria Docanto,Louise Kostos,Siavash Foroughi,Stephen Brown,Lisa-Jane K. Graham,Kate Mahon,Lisa G. Horvath,Shidong Jia,Manish Kohli,Arun Azad
出处
期刊:EBioMedicine
[Elsevier BV]
日期:2023-08-05
卷期号:95: 104738-104738
被引量:28
标识
DOI:10.1016/j.ebiom.2023.104738
摘要
Genomic alterations in DNA damage response (DDR) genes are common in metastatic castration-resistant prostate cancer (mCRPC). Understanding how these genomic events impact prognosis and/or treatment response is vital for optimising clinical outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI